Emergent is a life sciences company that develops vaccines and antibody therapies for the treatment of infectious diseases.
Business Model:
Revenue: $1.5B
Employees: 1,001-5,000
Address: 400 Professional Drive
City: Gaithersburg
State: MD
Zip: 20879
Country: US
Emergent is a life sciences company that develops vaccines and antibody therapies for the treatment of infectious diseases.
Contact Phone:
+12406313200
Contact Email:
Listed Exchange:
NYSE
IPO Date:
11/17/2006
Ticker Symbol:
EBS
IPO Price:
$12.5/share
Amount Raised:
$63M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2008 | Grant | $4.5M |
National Institute of Allergy and Infectious Diseases |
1/2014 | Convertible Note | $250M | 8/2020 | Debt | $450M | 4/2020 | Grant | 1 | $14.5M |
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) |
11/2022 | Grant | 1 | - |
U.S. Department of Defense U.S. Department of Defense |
9/2019 | Grant | $20M | 2/2015 | Post-IPO Debt | $2M |
---|
Announced Date | Name | Price |
---|---|---|
8/2018 | Adapt Pharma | |
8/2018 | PaxVax | |
7/2017 | Sanofi - smallpox vaccine | |
12/2013 | Cangene | |
8/2010 | Trubion Pharmaceuticals | |
6/2005 | Microscience |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|